Drug Trial Radar · NCT02222545
Safety and Efficacy Study of OMS721 in Patients With Thrombotic Microangiopathies
Last checked: Nov 20, 2026Latest source record: Aug 28, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
58
Actual
Start
Nov 2, 2014
Primary completion
Jan 30, 2020
Study completion Aug 11, 2020
Sponsor
- Lead sponsor
- Omeros CorporationIndustry
- Sponsor type
- Industry
- First posted
- Aug 21, 2014
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Non randomized
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to assess the safety, efficacy, pharmacokinetics (PK), pharmacodynamics (PD), and immunogenicity of OMS721 in patients with thrombotic microangiopathies (TMA).
Conditions
- Thrombotic Microangiopathies
Interventions
OMS721Biological
Primary outcomes
What the sponsor says the trial is designed to measure.
- Assess the Safety and Tolerability of Multiple-dose Administration of OMS721 in Participants With TMATime frame: Day 1 to 37 days after end of treatment, approximately up to 31 weeks.
- Number of Participants With HSCT-TMA Who Respond to OMS721Time frame: Day 1 to up to 2 years following the first dose of OMS721
Locations
24 sites in 12 countries. Site status is shown where the registry gives one.
Omeros Investigational Site
Duarte, California
Omeros Investigational Site
Rochester, Minnesota
Omeros Investigational Site
New York, New York
Omeros Investigational Site
Durham, North Carolina
Omeros Investigational Site
Madison, Wisconsin
Omeros Investigational Site
Brussels, Belgium
Omeros Investigational Site
Leuven, Belgium
Omeros Investigational Site
Liège, Belgium
Omeros Investigational Site
Sofia, Bulgaria
Omeros Investigational Site
Shatin, Hong Kong
Omeros Investigational Site
Bergamo, Italy
Omeros Investigational Site
Vilnius, Lithuania
Omeros Investigational Site
Selangan, Malaysia
Omeros Investigational Site
Christchurch, New Zealand
Omeros Investigational Site
Katowice, Poland
Omeros Investigational Site
Krakow, Poland
Omeros Investigational Site
Lodz, Poland
Omeros Investigational Site
Warsaw, Poland
Omeros Investigational Site
Singapore, Singapore
Omeros Investigational Site
Taichung, Taiwan
Omeros Investigational Site
Taipei, Taiwan
Omeros Investigational Site
Ban Pathumwan, Thailand
Omeros Investigational Site
Bangkok, Thailand
Omeros Investigational Site
Pathum Thani, Thailand
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.